statistiche per MAGISTRONI, Riccardo

Distribuzione geografica

Continente	#
NA - Nord America	5788
EU - Europa	2819
AS - Asia	384
SA - Sud America	14
Continente sconosciuto - Info sul continente non disponibili	10
AF - Africa	6
OC - Oceania	6
Totale	9027

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	5763
GB - Regno Unito	768
DE - Germania	677
IT - Italia	613
UA - Ucraina	203
SE - Svezia	144
CN - Cina	135
TR - Turchia	119
BG - Bulgaria	107
RU - Federazione Russa	101
FR - Francia	95
FI - Finlandia	51
IN - India	28
CA - Canada	22
VN - Vietnam	22
MY - Malesia	14
ES - Italia	11
IR - Iran	11
HK - Hong Kong	10
KR - Corea	10
NL - Olanda	9
EU - Europa	8
RO - Romania	8
IE - Irlanda	7
AU - Australia	6
DK - Danimarca	6
IL - Israele	5
BR - Brasile	4
CO - Colombia	4
ID - Indonesia	4
JP - Giappone	4
PK - Pakistan	4
TW - Taiwan	4
AL - Albania	3
BD - Bangladesh	3
IQ - Iraq	3
MD - Moldavia	3
A2 - ???statistics.table.value.countryCode.A2???	2
AT - Austria	2
GR - Grecia	2
HR - Croazia	2
KZ - Kazakistan	2
MA - Marocco	2
MT - Malta	2
MX - Messico	2
SC - Seychelles	2
TN - Tunisia	2
VE - Venezuela	2
AR - Argentina	1
AZ - Azerbaigian	1
BA - Bosnia-Erzegovina	1
BE - Belgio	1
CH - Svizzera	1
CL - Cile	1
EC - Ecuador	1
GE - Georgia	1
GT - Guatemala	1
JO - Giordania	1
PE - Perù	1
PH - Filippine	1
PL - Polonia	1
SG - Singapore	1
SM - San Marino	1
TH - Thailandia	1
Totale	9027

Salva come PNG Salva come JPEG

Città	#
Fairfield	1167
Southend	699
Woodbridge	631
Houston	529
Ashburn	458
Seattle	433
Wilmington	426
Cambridge	374
Jacksonville	354
Ann Arbor	285
Dearborn	250
Modena	176
San Diego	112
Sofia	107
Eugene	69
Redwood City	66
Beijing	56
Izmir	47
Falls Church	26
Fremont	24
Norwalk	21
Milan	19
Nanjing	16
Leawood	15
Napoli	15
San Mateo	15
Dong Ket	13
Phoenix	13
Andover	11
Bologna	11
Hefei	9
Augusta	8
Central District	8
Rome	8
Hanoi	7
Torre Del Greco	7
Dallas	6
Formigine	6
Kunming	6
Ottawa	6
Auburn Hills	5
Guangzhou	5
San Giuliano Milanese	5
Santa Margherita Ligure	5
Toronto	5
Verona	5
Changsha	4
Chengdu	4
Grafing	4
Saint Louis	4
San Francisco	4
Utrecht	4
Wuhan	4
Abbiategrasso	3
Ankara	3
Bolzano	3
Brescia	3
Castelnuovo Rangone	3
Chisinau	3
Duncan	3
Faenza	3
Ferrara	3
Florence	3
Indiana	3
Jinan	3
Monserrato	3
Montegaldella	3
Mumbai	3
Nanchang	3
Palermo	3
Parma	3
Pietra Ligure	3
Pozzuoli	3
Prata	3
Rho	3
Segrate	3
Treviglio	3
Adelaide	2
Agliè	2
Barano D'ischia	2
Bari	2
Castelfiorentino	2
Castellarano	2
Cecina	2
Cornaredo	2
Córdoba	2
Encino	2
Fuzhou	2
Gurgaon	2
Hangyang	2
Hanover	2
Herzliya	2
Islamabad	2
Jakarta	2
Karlsruhe	2
Kashan	2
Köln	2
Limerick	2
Lyons	2
Melbourne	2
Totale	6685

Salva come PNG Salva come JPEG

Nome	#
The prevalence of autosomal dominant polycystic kidney disease (ADPKD): A meta-analysis of European literature and prevalence evaluation in the Italian province of Modena suggest that ADPKD is a rare and underdiagnosed condition	203
Interstitial fluid obtained from kidney biopsy as new source of renal biomarkers	198
Identification and Characterization of New Proteins in Podocyte Dysfunction of Membranous Nephropathy by Proteomic Analysis of Renal Biopsy	196
Identification and characterization of a new autoimmune protein in membranous nephropathy by immunoscreening of a renal cDNA library	187
CD133 and CD24 expression in renal tissue of patients affected by autosomal dominant polcystic kidney disease	185
Corticosteroids in IgA nephropathy: A retrospective analysis from the VALIGA study	183
New developments in the genetics, pathogenesis, and therapy of IgA nephropathy	175
Tonsillectomy in a European Cohort of 1,147 Patients with IgA Nephropathy	169
Comparison of Total Kidney Volume Quantification Methods in Autosomal Dominant Polycystic Disease for a Comprehensive Disease Assessment	169
Lipoprotein glomerulopathy treated with LDL-apheresis (Heparin-induced Extracorporeal Lipoprotein Precipitation system): a case report.	167
Can tonsillectomy modify the innate and adaptive immunity pathways involved in IgA nephropathy?	165
Deciphering Variability of PKD1 and PKD2 in an Italian Cohort of 643 Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD)	158
Tolvaptan in patients with autosomal dominant polycystic kidney disease	157
Approccio pratico alla terapia del paziente affetto da Rene Policistico Autosomico Dominante	156
Plasma exchange in acute and chronic hyperviscosity syndrome: a rheological approach and guidelines study	153
I polimorfismi del gene dell’enzima di conversione dell’angiotensina (ACE) nel rene policistico autosomico dominante (ADPKD)	147
Pregnancy and progression of IgA nephropathy: results of an Italian multicenter study	144
Lipoprotein glomerulopathy associated with a mutation in apolipoprotein e	143
Il rene policistico autosomico dominante (ADPKD): aspetti genetico-molecolari, clinici ed epidemiologici nella provincia di Modena.	142
Confidence Calibration for Deep Renal Biopsy Immunofluorescence Image Classification	139
Genotype-renal function correlation in type 2 autosomal dominant polycystic kidney disease	139
Genome-wide association study identifies susceptibility loci for IgA nephropathy	136
Influence of ACE I/D gene polymorphism in the progression of renal failure in autosomal dominant polycystic kidney disease: a meta-analysis	135
Tolvaptan: Clinical Evidence for Slowing the Progression of Autosomal Dominant Polycystic Kidney Disease	133
Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments	132
Precocious activation of genes of the renin-angiotensin system and the fibrogenic cascade in IgA glomerulonephritis	132
Trattato di Medicina Interna : Le Sindromi Renali.	130
Proteomic analysis of urine from proteinuric patients shows a proteolitic activity directed against albumin	129
Comment on the paper: 'novel approach to estimate kidney and cyst volumes using mid-slice magnetic resonance images in polycystic kidney disease'	129
A pilot study to evaluate Tolerability and Safety of a Modified Atkins Diet in ADPKD patients	126
Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens	126
Defective glycolysis and the use of 2-deoxy-d-glucose in polycystic kidney disease: from animal models to humans	124
Geometry-independent assessment of renal volume in polycystic kidney disease from magnetic resonance imaging	123
APOE MODENA : A NOVEL APOE MUTANT CAUSING LIPOPROTEIN GLOMERULOPATHY	123
Reliability of Total Renal Volume Computation in Polycystic Kidney Disease From Magnetic Resonance Imaging	123
COVID-19 pneumonia in a kidney transplant recipient successfully treated with tocilizumab and hydroxychloroquine	122
Advances in genetics of Immunoglobulin A Nephropathy.	120
Coexistence of different circulating anti-podocyte antibodies in membranous nephropathy	120
Unified criteria for ultrasonographic diagnosis of ADPKD	116
Evaluation of the Classification Accuracy of the Kidney Biopsy Direct Immunofluorescence through Convolutional Neural Networks	115
The MEST score provides earlier risk prediction in lgA nephropathy	114
Direct characterization of target podocyte antigens and auto-antibodies in human membranous glomerulonephritis: Alfa-enolase and borderline antigens	114
Genetic variation of DKK3 may modify renal disease severity in ADPKD	108
The definition of chronic kidney disease in a context of aging population	107
Genome-wide linkage scan of a large family with IgA nephropathy localizes a novel susceptibility locus to chromosome 2q36.	106
Urine Proteome Analysis May Allow Non-Invasive Differential Diagnosis of Diabetic Nephropathy	103
A validated model of disease progression in IgA nephropathy	96
Autosomal dominant polycystic kidney disease: from genes to cilium.	95
Interstitiome: a novel proteomic discipline applied to renal biopsy	94
Epidermal growth factor receptor polymorphism and autosomal dominant polycystic kidney disease	93
GREASE II. A phase II randomized, 12-month, parallel-group, superiority study to evaluate the efficacy of a Modified Atkins Diet in Autosomal Dominant Polycystic Kidney Disease patients	92
Screening of a kidney cDNA library for the identification of autoimmune proteins from serum of membranous nephropathy patients.	90
Primary IgA nephropathy is more severe in TGF-beta1 high secretor patients.	89
Il Registro Italiano del Rene PolicisticoAutosomico Dominante	86
MALATTIE DEL RENE, DELLE VIE URINARIE E DELL'APPARATO GENITALE MASCHILE : Le Nefropatie Glomerulari: glomerulonefriti primitive; glomerulonefriti secondarie	85
Oxalate Nephropathy Caused by Excessive Vitamin C Administration in 2 Patients With COVID-19	84
Hypokalemia in Patients with COVID-19	84
Progressive loss of renal function is an age-dependent heritable trait in type 1 autosomal dominant polycystic kidney disease	80
Evaluation of coronary artery disease by multislice spiral computed tomography in dialysis patients	76
ADPKD current management and ongoing trials	75
HEMOREOLOGIC PROFILE OF KIDNEY TRANSPLANT RECIPIENTS: A ROLE IN CARDIOVASCULAR RISK?	72
Peritoneal dialysis in the time of coronavirus disease 2019	68
[Clinical diagnosis of Autosomal Dominant Polycystic Kidney Disease]	63
The Role of the Renin-Angiotensin System in Severe Acute Respiratory Syndrome-CoV-2 Infection	59
Development and testing of an artificial intelligence tool for predicting end-stage kidney disease in patients with immunoglobulin A nephropathy	59
Monoclonal antibodies in nephrology: a delicate balance between curative potential, evidence of effectiveness, and toxicity	58
[Genetics and genetic counseling]	55
Long-term effects of COVID-19 in a patient on maintenance dialysis	55
HEMORHEOLOGY IN RENAL TRANSPLANTATION	54
[Screening for cerebral aneurysms in the ADPKD population: mandatory or potentially harmful?]	54
Towards evidence-based nephrology: the seeming paradox of "out-of-line" guidelines.	53
Insufficienza renale gestione della uremia e della terapia sostitutiva	51
Hybrid dialysis: A promising strategy to reduce hospital access during the SARS-CoV-2 pandemic	47
Evaluating a New International Risk-Prediction Tool in IgA Nephropathy	45
[Diagnosis in Polycystic Kidney Disease]	44
Clinical Presentation, Renal Histopathological Findings, and Outcome in Patients with Monoclonal Gammopathy and Kidney Disease	42
Improving treatment decisions using personalized risk assessment from the International IgA Nephropathy Prediction Tool	41
Erratum: The Role of the Renin-Angiotensin System in Severe Acute Respiratory Syndrome-CoV-2 Infection (Journal of Physical Chemistry DOI: 10.1159/000507914)	41
One-year persistence of neutralizing anti-SARS-CoV-2 antibodies in dialysis patients recovered from COVID-19	38
The frail world of haemodialysis patients in the COVID-19 pandemic era: a systematic scoping review	38
A Review of the Imaging Techniques for Measuring Kidney and Cyst Volume in Establishing Autosomal Dominant Polycystic Kidney Disease Progression	37
The underlying cause of kidney disease is often unknown in dialysis patients: a possible genomic approach	36
Quantifying duration of proteinuria remission and association with clinical outcome in IgA nephropathy	36
SARS-CoV-2 infection in dialysis patients in northern Italy: A single-centre experience	34
Response letter to the Editorial: "Ketogenic diet in ADPKD patients"	34
Acid base disorders in patients with COVID-19	33
TRPP2 dysfunction decreases ATP-evoked calcium, induces cell aggregation and stimulates proliferation in T lymphocytes	31
Twenty-four-hour serum creatinine variation is associated with poor outcome in the novel coronavirus disease 2019 (COVID-19) patients	30
Seroconversion after COVID-19 vaccine in a dialysis patient on immunosuppressants	26
Methicillin-Resistant Staphylococcus aureus Peritonitis due to Hematogenous Dissemination from Central Venous Catheter in a Maintenance Dialysis Patient	26
Rituximab versus steroids and cyclophosphamide for the treatment of primary membranous nephropathy: Protocol of a pilot randomised controlled trial	24
Monoclonal B lymphocytosis in a kidney transplant recipient	22
Clinical Predictors of Nondiabetic Kidney Disease in Patients with Diabetes: A Single-Center Study	22
Incidence, risk factors and outcome of acute kidney injury (AKI) in patients with COVID-19	21
AKI in hospitalized patients with COVID-19: a single-center experience	20
Rituximab or Cyclophosphamide in the Treatment of Membranous Nephropathy: The RI-CYCLO Randomized Trial	19
Reproducibility of the Oxford classification of immunoglobulin A nephropathy, impact of biopsy scoring on treatment allocation and clinical relevance of disagreements: Evidence from the VALidation of IGA study cohort	16
Is there long-term value of pathology scoring in immunoglobulin A nephropathy? A validation study of the Oxford Classification for IgA Nephropathy (VALIGA) update	16
Immunosuppressive therapy reduction and early post-infection graft function in kidney transplant recipients with COVID-19	11
Erratum: SARS-CoV-2 infection in dialysis patients in northern Italy: A single-centre experience (Clinical Kidney Journal (2020) 13:3 (334-339) DOI: 10.1093/ckj/sfaa084)	11
Totale	9282

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	9297
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	9297

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2016/2017	19	0	0	0	0	0	0	0	0	0	0	0	19
2017/2018	603	43	0	19	84	42	195	25	58	30	55	29	23
2018/2019	1317	65	94	54	81	83	85	109	56	29	105	259	297
2019/2020	2195	150	146	83	130	219	344	331	205	225	94	155	113
2020/2021	2628	189	136	211	189	248	255	230	294	132	351	255	138
2021/2022	2223	180	206	223	166	100	131	130	138	260	189	371	129
Totale													9297